A detailed history of Bahl & Gaynor Inc transactions in Conmed Corp stock. As of the latest transaction made, Bahl & Gaynor Inc holds 15,498 shares of CNMD stock, worth $1.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,498
Previous 15,434 0.41%
Holding current value
$1.04 Million
Previous $1.69 Million 26.57%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$75.36 - $112.51 $4,823 - $7,200
64 Added 0.41%
15,498 $1.24 Million
Q4 2023

Feb 02, 2024

BUY
$91.3 - $115.05 $18,899 - $23,815
207 Added 1.36%
15,434 $1.69 Million
Q3 2023

Nov 03, 2023

BUY
$97.55 - $135.91 $1,170 - $1,630
12 Added 0.08%
15,227 $1.54 Million
Q2 2023

Aug 14, 2023

SELL
$102.55 - $136.38 $1,538 - $2,045
-15 Reduced 0.1%
15,215 $2.07 Million
Q1 2023

May 03, 2023

SELL
$89.75 - $107.27 $1.08 Million - $1.29 Million
-11,984 Reduced 44.04%
15,230 $1.58 Million
Q4 2022

Feb 10, 2023

SELL
$72.84 - $94.04 $619,577 - $799,904
-8,506 Reduced 23.81%
27,214 $2.41 Million
Q3 2022

Nov 14, 2022

SELL
$77.78 - $103.92 $970,849 - $1.3 Million
-12,482 Reduced 25.9%
35,720 $2.86 Million
Q2 2022

Aug 08, 2022

BUY
$88.23 - $154.18 $69,260 - $121,031
785 Added 1.66%
48,202 $4.62 Million
Q1 2022

May 12, 2022

SELL
$121.88 - $150.0 $168,560 - $207,450
-1,383 Reduced 2.83%
47,417 $7.04 Million
Q4 2021

Feb 10, 2022

BUY
$129.86 - $157.03 $11,038 - $13,347
85 Added 0.17%
48,800 $6.92 Million
Q3 2021

Nov 15, 2021

BUY
$122.87 - $139.12 $18,061 - $20,450
147 Added 0.3%
48,715 $6.37 Million
Q2 2021

Aug 06, 2021

SELL
$128.08 - $145.09 $389,491 - $441,218
-3,041 Reduced 5.89%
48,568 $6.68 Million
Q1 2021

May 11, 2021

BUY
$111.35 - $130.59 $142,639 - $167,285
1,281 Added 2.55%
51,609 $6.74 Million
Q4 2020

Feb 02, 2021

BUY
$77.7 - $112.82 $63,947 - $92,850
823 Added 1.66%
50,328 $5.64 Million
Q3 2020

Nov 12, 2020

SELL
$69.87 - $89.2 $92,228 - $117,744
-1,320 Reduced 2.6%
49,505 $3.9 Million
Q2 2020

Aug 13, 2020

BUY
$50.31 - $81.76 $5,584 - $9,075
111 Added 0.22%
50,825 $3.66 Million
Q1 2020

May 26, 2020

BUY
$39.81 - $112.01 $2.02 Million - $5.68 Million
50,714 New
50,714 $2.9 Million
Q1 2020

May 15, 2020

SELL
$39.81 - $112.01 $1.47 Million - $4.12 Million
-36,822 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$93.31 - $116.55 $14,836 - $18,531
159 Added 0.43%
36,822 $4.12 Million
Q3 2019

Nov 14, 2019

BUY
$83.97 - $102.19 $681,080 - $828,863
8,111 Added 28.41%
36,663 $3.53 Million
Q2 2019

Aug 12, 2019

BUY
$78.27 - $86.94 $2.23 Million - $2.48 Million
28,552 New
28,552 $2.44 Million

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.04B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.